861106-92-5

Basic information

• Product Name: (2-Amino-6-bromo-phenyl)-methanol
• Synonyms: (2-Amino-6-bromo-phenyl)-methanol;Benzenemethanol, 2-amino-6-bromo-
• CAS NO: 861106-92-5
• Molecular Formula: C₇H₈BrNO
• Molecular Weight: 202.04852
• Mol File: 861106-92-5.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 341.4±27.0 °C(Predicted)
• Appearance: /
• Density: 1.660±0.06 g/cm3(Predicted)
• PKA: 13.80±0.10(Predicted)
• CAS DataBase Reference: (2-Amino-6-bromo-phenyl)-methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (2-Amino-6-bromo-phenyl)-methanol(861106-92-5)
• EPA Substance Registry System: (2-Amino-6-bromo-phenyl)-methanol(861106-92-5)

Safety Data

• Hazardous Substances Data: 861106-92-5(Hazardous Substances Data)

Usage

General Description

(2-Amino-6-bromo-phenyl)-methanol is a chemical compound with the molecular formula C7H8BrNO. It is a white to light beige solid with a molecular weight of 204.05 g/mol. (2-Amino-6-bromo-phenyl)-methanol is commonly used as an intermediate in the synthesis of pharmaceuticals and organic compounds. It possesses a variety of potential biological activities, including antimicrobial, antiviral, and antiparasitic properties. Additionally, it has been investigated for its potential as a building block for the preparation of various heterocyclic compounds. Its versatile properties make it a valuable chemical in the field of medicinal chemistry and drug development.

Upstream product

• 58579-54-7 3-bromo-2-(bromomethyl)-1-nitrobenzene 
• 55289-35-5 2-bromo-6-nitrotoluene 
• 861106-90-3 2-bromo-6-nitrobenzyl acetate 
• 20776-48-1 2-amino-6-chlorobenzoic acid 
• 5794-88-7 5-Bromo-2-aminobenzoic acid 
• 861106-91-4 (2-bromo-6-nitro-phenyl)-methanol 

Downstream Products

• 1347720-73-3 C₂₁H₂₄BrN₃O₅ 
• 1374764-25-6 C₁₈H₁₆BrN₃O₃ 
• 1394358-00-9 5-bromo-2-(3,5-dimethylphenyl)quinoline 
• 1404491-68-4 2-(3,5-dimethylphenyl)-5-(trimethylsilyl)quinoline 
• 1899832-38-2 5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2,4-dihydro-1H-3,1-benzoxazin-2-one 
• 1147531-04-1 3-bromo-2-[[tert-butyl(dimethyl)silyl]oxymethyl] aniline 
• 1160244-38-1 5-bromo-2-phenyl-1,4-dihydro-2H-benzo[d][1,3]oxazine 
• 861106-93-6 5-bromo-2,4-dihydro-1H-3,1-benzoxazin-2-one 
• 1347721-40-7 C₁₉H₂₀BrN₃O₂ 

Relevant articles and documents

Metal-Free C-C/C-N/C-C Bond Formation Cascade for the Synthesis of (Trifluoromethyl)sulfonylated Cyclopenta[ b]indolines

A bis(triflyl)ethylation [triflyl = (trifluoromethyl)sulfonyl] inserted into a sequential cyclization cascade resulted in the direct formation of gem-bis(triflyl)ated cyclopenta[b]indolines from anilide-derived allenols and alkenols. This catalyst- and irradiation-free sequence facilitated the efficient preparation of functionalized tricyclic indoline cores bearing two contiguous stereocenters. The formed cyclopenta[b]indolines can be easily transformed into a wide variety of triflylated indolines, including the tetracycle ring system found in polyveoline.

Red phosphorescent compound and organic electroluminescent device using same

The invention discloses a red phosphorescent compound and an organic electroluminescent device using the same. In an organic electroluminescent device comprising an anode, a hole injection layer, a hole transport layer, a light-emitting layer, an electron

FUSED QUINAZOLINE DERIVATIVES AND USES THEREOF

Fused quinazoline derivatives and uses thereof as protein tyrosine kinase inhibitors and aurora kinase inhibitors are disclosed. Said protein tyrosine kinase inhibitors and aurora kinase inhibitors can be used in treating cancers, leukaemia and the diseases relevant to differentiation and proliferation. Said protein tyrosine kinase and aurora kinase dual inhibitors are the compounds represented by the following general formula or salts thereof.